Gene · 7075
Papers2,045
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,045
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Quantifying the impact of strong ties in international scientific research collaboration. | PLoS One | 2023 | 36649356 | PubTator, text mining | PubMed |
| BEYOND THE ENDOTHELIUM: THE ROLE OF MURAL CELLS IN VASCULAR BIOLOGY: In vitro systems to study endothelial/pericyte cell interactions. | Vasc Biol | 2023 | 36645735 | PubTator, text mining | PubMed |
| A dissected LMO2 functional analysis and clinical relevance in brain gliomas. | Biochem Biophys Rep | 2023 | 36545566 | PubTator, text mining | PubMed |
| Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE). | Cancer Med | 2023 | 36515003 | PubTator, text mining | PubMed |
| ETV2 Upregulation Marks the Specification of Early Cardiomyocytes and Endothelial Cells During Co-differentiation. | Stem Cells | 2023 | 36512477 | PubTator, text mining | PubMed |
| PARP inhibition promotes endothelial-like traits in melanoma cells and modulates pericyte coverage dynamics during vasculogenic mimicry. | J Pathol | 2023 | 36484652 | PubTator, text mining | PubMed |
| In Vitro Generation of Luminal Vasculature in Liver Organoids: From Basic Vascular Biology to Vascularized Hepatic Organoids. | Int J Stem Cells | 2023 | 36310029 | PubTator, text mining | PubMed |
| The peritumoral brain zone in glioblastoma: where we are and where we are going. | J Neurosci Res | 2023 | 36300592 | PubTator, text mining | PubMed |
| Inhibition of ANGPT2 activates autophagy during hypertrophic scar formation via PI3K/AKT/mTOR pathway. | An Bras Dermatol | 2023 | 36272879 | PubTator, text mining | PubMed |
| Molecular hallmarks of long non-coding RNAs in aging and its significant effect on aging-associated diseases. | Neural Regen Res | 2023 | 36254975 | PubTator, text mining | PubMed |
| Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance. | Annu Rev Pathol | 2023 | 36130070 | PubTator, text mining | PubMed |
| Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders. | Neuropsychopharmacology | 2023 | 36114287 | PubTator, text mining | PubMed |
| Reduced Angiopoietin Factor 2 Levels Are Correlated with Better Cardiac Function and Prognosis in Valvular Heart Disease. | Braz J Cardiovasc Surg | 2023 | 35657310 | PubTator, text mining | PubMed |
| APOLD1 loss causes endothelial dysfunction involving cell junctions, cytoskeletal architecture, and Weibel-Palade bodies, while disrupting hemostasis. | Haematologica | 2023 | 35638551 | PubTator, text mining | PubMed |
| Construction of ovarian metastasis-related immune signature predicting prognosis of gastric cancer patients. | Cancer Med | 2023 | 35621244 | PubTator, text mining | PubMed |
| Biallelic ANGPT2 loss-of-function causes severe early-onset non-immune hydrops fetalis. | J Med Genet | 2023 | 34876502 | PubTator, text mining | PubMed |
| Plasma angiopoietin 2 as a novel prognostic biomarker in alcohol-related cirrhosis and hepatitis. | Liver Res | 2022 | 39959809 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomic Census of Endothelial Changes Induced by Matrix Stiffness and the Association with Atherosclerosis. | Adv Funct Mater | 2022 | 36816792 | PubTator, text mining | PubMed |
| The impact of decreased expression of SVEP1 on abnormal neovascularization and poor prognosis in patients with intrahepatic cholangiocarcinoma. | Front Genet | 2022 | 36699464 | PubTator, text mining | PubMed |
| Diabetic retinopathy: Looking forward to 2030. | Front Endocrinol (Lausanne) | 2022 | 36699020 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7075/papers?page=15